← Back to all trials
Not Yet Recruiting
NCT05673135
The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women
Conditions: Hypertension in Pregnancy
Sex: Female
Ages: 25 Years – 35 Years
Phase: NA
Enrollment: 260
Sponsor: Assiut University
Location: Egypt
Summary
Hypertensive disorders of pregnancy, include pre-existing and gestational hypertension, preeclampsia, and eclampsia, it complicates up to 10% of pregnancies and represents a significant cause of maternal and perinatal morbidity and mortality.
Following the "National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy" recommendation is currently a systolic blood pressure (SBP) ⩾ of 140 mmHg and diastolic blood pressure (DBP) ⩾ of 90 mmHg.
The diagnosis generally requires two separate measurements.
Accepted across international guidelines are the following four categories: Chronic/pre-existing hypertension (Hypertension discovered preconception or prior to 20 weeks gestation), Gestational hypertension (Hypertension that appears de novo after 20 weeks gestation and normalizes after pregnancy), Preeclampsia-eclampsia (De novo hypertension after 20 weeks' gestation accompanied by proteinuria, other features of maternal organ dysfunction or uteroplacental dysfunction), Chronic/pre-existing hypertension with superimposed preeclampsia-eclampsia.
Over the past 2 decades, extensive epidemiologic studies have clearly established that obesity is a major risk for gestational hypertension and preeclampsia.
The risk of preeclampsia typically doubles with each 5-7 kg/m2 increase in pre-pregnancy.
The mechanisms have only been partially explored; increased cytokine-mediated inflammation and oxidative stress, increased shear stress, dyslipidemia, and increased sympathetic activity1 have all been proposed as possible pathways.
Few studies have examined the relationship between pre-pregnancy BMI, gestational weight gain (GWG), and the risk of preeclampsia.
So, our study aims to evaluate the adverse maternal and fetal outcomes related to hypertension in obese and non-obese pregnant women.
Eligibility Criteria
Inclusion Criteria:Women aged from 20-35 years.Pregnant women from 28-30 weeks.Pregnant women with a singleton pregnancy.Women with chronic or gestational hypertension.Women with normal baseline investigations (uncomplicated hypertension).Obese women and non-obese women.Exclusion Criteria:Women with preeclampsia/eclampsia.Women need urgent termination of pregnancy.Women with co-morbidities such as diabetes, renal diseases, cardiac ...etc.Women with confirmed fetal malformation.Women who will refuse to participate.
Source: ClinicalTrials.gov (NCT05673135). StuddyBuddy aggregates publicly available trial information.